The role of selective internal radiotherapy with Y-90 resin microsphere in first-line therapy for hepatic colorectal metastases
- PMID: 30498713
- PMCID: PMC6230849
- DOI: 10.21037/hbsn.2018.06.09
The role of selective internal radiotherapy with Y-90 resin microsphere in first-line therapy for hepatic colorectal metastases
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources